首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Ethnopharmacokinetic- and Activity-Guided Isolation of a New Antidepressive Compound from Fructus Aurantii Found in the Traditional Chinese Medicine Chaihu-Shugan-San: A New Approach and Its Application
【24h】

Ethnopharmacokinetic- and Activity-Guided Isolation of a New Antidepressive Compound from Fructus Aurantii Found in the Traditional Chinese Medicine Chaihu-Shugan-San: A New Approach and Its Application

机译:从中药柴胡-舒肝散中发现的Au皮中新的抗抑郁化合物的民族药代动力学和活性指导分离:一种新方法及其应用

获取原文
获取原文并翻译 | 示例
       

摘要

Aims. We aimed to identify an antidepressive compound found in traditional Chinese medicine (TCM) by a new approach called ethnopharmacokinetic- and activity-guided isolation (EAGI). Methods. The new approach targets an unknown chromatographic peak produced by an absorbed compound found in oral Chaihu-Shugan-San (CSS) taken by patients with depression. Once the compound was isolated from Fructus Aurantii (FA), spectral data was employed to identify the compound. The effects of this compound, FA, and CSS on depressive behaviors were investigated. Results. The identified compound was merazin hydrate (MH) according to the new approach. MH, FA, and CSS significantly reduced immobility time and increased locomotor activity. The effects of MH, FA and CSS were similar to Fluoxetine at high doses. Conclusion. MH, a compound whose antidepressive effect is similar to FA and CSS, was isolated for the first time from FA via targeting its corresponding unknown chromatographic peak, and its antidepressive effect was compared with FA or CSS. These findings highlight the potential for drug R&D and pharmacological research of ~ 100,000 TCMs.
机译:目的我们旨在通过一种名为民族药代动力学和活性指导隔离(EAGI)的新方法,鉴定中药(TCM)中发现的抗抑郁化合物。方法。新方法的目标是未知的色谱峰,该峰是由抑郁症患者在口服Chaihu-Shugan-San(CSS)中发现的吸收化合物产生的。一旦从金合欢(FA)中分离出化合物,就使用光谱数据来鉴定化合物。研究了该化合物,FA和CSS对抑郁行为的影响。结果。根据新方法,鉴定出的化合物为水合甲拉嗪(MH)。 MH,FA和CSS可显着减少固定时间并增加运动能力。高剂量时,MH,FA和CSS的作用与氟西汀相似。结论。 MH是一种抗抑郁作用类似于FA和CSS的化合物,它首次通过靶向其相应的未知色谱峰从FA中分离出来,并将其抗抑郁作用与FA或CSS进行了比较。这些发现凸显了约100,000种中药的药物研发和药理研究潜力。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号